Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy (Q41553085)
Jump to navigation
Jump to search
scientific article published on November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy |
scientific article published on November 2014 |
Statements
1 reference
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy (English)
1 reference
Carlo F Perno
1 reference
Julio S G Montaner
1 reference
Richard Harrigan
1 reference
José L Blanco
1 reference
Ariel E Campos-Loza
1 reference
Robert W Shafer
1 reference
Michael D Miller
1 reference
Roger Paredes
1 reference
Mihn L Nguyen
1 reference
Lucero A Gonzalez-Hernandez
1 reference
José M Gatell
1 reference
1 November 2014
1 reference
1 reference
28
1 reference
17
1 reference
2531-2539
1 reference
Identifiers
1 reference
1 reference